Licensing
🇺🇸 FDA Page 5FDA news and analysis for pharmaceutical BD, investment, and market access · 11 articles on this page
Unlock global pharma market opportunities. Get expert insights on drug licensing deals, IP strategies, and M&A trends for strategic BD.
Showing 49–59 of 59 articles
Parabilis IPO Plans Following Regeneron Deal: What You Need to Know
Bristol Myers Expands AI Capabilities with Anthropic Partnership
Supreme Court Decision on IRA Challenges: Implications for Pharma
Regeneron Secures $125M Parabilis Deal for Drug Targets
Pfizer's Latest Developments: Insights for Investors and Executives
U.K. Advocacy Groups Challenge U.S. Pharma Trade Deal
Biopharma M&A Trends: Resilience Amidst Large Deal Decline
M&A Trends: Mid-Size Pharma Companies on the Rise
Pharma Partnering US: $77.3B Licensing Deals in Q1 2026
Pharma Partnering US: Biotech Dealmaking Heats Up
FDLI 2026: FDA Leaders to Discuss Strategic Priorities